Welcome to LookChem.com Sign In|Join Free

CAS

  • or

656827-62-2

Post Buying Request

656827-62-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

656827-62-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 656827-62-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,5,6,8,2 and 7 respectively; the second part has 2 digits, 6 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 656827-62:
(8*6)+(7*5)+(6*6)+(5*8)+(4*2)+(3*7)+(2*6)+(1*2)=202
202 % 10 = 2
So 656827-62-2 is a valid CAS Registry Number.

656827-62-2Downstream Products

656827-62-2Relevant articles and documents

Synthesis, Biological Properties, and Molecular Modeling Investigations of Novel 3,4-Diarylpyrazolines as Potent and Selective CB1 Cannabinoid Receptor Antagonists

Lange, Jos H. M.,Coolen, Hein K. A. C.,Van Stuivenberg, Herman H.,Dijksman, Jessica A. R.,Herremans, Arnoud H. J.,Ronken, Eric,Keizer, Hiskias G.,Tipker, Koos,McCreary, Andrew C.,Veerman, Willem,Wals, Henri C.,Stork, Bob,Verveer, Peter C.,Den Hartog, Arnold P.,De Jong, Natasja M. J.,Adolfs, Tiny J. P.,Hoogendoorn, Jan,Kruse, Chris G.

, p. 627 - 643 (2007/10/03)

A series of novel 3,4-diarylpyrazolines was synthesized and evaluated in cannabinoid (hCB1 and hCB2) receptor assays. The 3,4-diarylpyrazolines elicited potent in vitro CB1 antagonistic activities and in general exhibited high CB1 vs CB2 receptor subtype selectivities. Some key representatives showed potent pharmacological in vivo activities after oral dosing in both a CB agonist-induced blood pressure model and a CB agonist-induced hypothermia model. Chiral separation of racemic 67, followed by crystallization and an X-ray diffraction study, elucidated the absolute configuration of the eutomer 80 (SLV319) at its C4 position as 4S. Bioanalytical studies revealed a high CNS-plasma ratio for the development candidate 80. Molecular modeling studies showed a relatively close three-dimensional structural overlap between 80 and the known CB1 receptor antagonist rimonabant (SR141716A). Further analysis of the X-ray diffraction data of 80 revealed the presence of an intramolecular hydrogen bond that was confirmed by computational methods. Computational models and X-ray diffraction data indicated a different intramolecular hydrogen bonding pattern in the in vivo inactive compound 6. In addition, X-ray diffraction studies of 6 revealed a tighter intermolecular packing than 80, which also may contribute to its poorer absorption in vivo. Replacement of the amidine -NH2 moiety with a -NHCH3 group proved to be the key change for gaining oral biovailability in this series of compounds leading to the identification of 80.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 656827-62-2